Paul C - Search Results

1

Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome p450 genes by ciprofloxacin.

Xie HJ, Broberg U, Griskevicius L, Lundgren S, Carlens S, Meurling L, Paul C, Rane A, Hassan M. Xie HJ, et al. Among authors: paul c. Bone Marrow Transplant. 2003 Feb;31(3):197-203. doi: 10.1038/sj.bmt.1703815. Bone Marrow Transplant. 2003. PMID: 12621481

2

Effects of retinoids on cell toxicity and apoptosis in leukemic blast cells from patients with non-M3 AML.

Lehmann S, Bengtzen S, Broberg U, Paul C. Lehmann S, et al. Among authors: paul c. Leuk Res. 2000 Jan;24(1):19-25. doi: 10.1016/s0145-2126(99)00153-8. Leuk Res. 2000. PMID: 10634641

3

Higher plasma but not intracellular concentrations after infusion with liposomal daunorubicin compared with conventional daunorubicin in adult acute myeloid leukemia.

Löfgren C, Lehmann S, Jönsson-Videsäter K, Möllgård L, Linder O, Tidefelt U, Hassan M, Paul C. Löfgren C, et al. Among authors: paul c. Ther Drug Monit. 2007 Oct;29(5):626-31. doi: 10.1097/FTD.0b013e318156e938. Ther Drug Monit. 2007. PMID: 17898654

4

Cardiac systolic function before and after hematopoietic stem cell transplantation.

Lehmann S, Isberg B, Ljungman P, Paul C. Lehmann S, et al. Among authors: paul c. Bone Marrow Transplant. 2000 Jul;26(2):187-92. doi: 10.1038/sj.bmt.1702466. Bone Marrow Transplant. 2000. PMID: 10918429

5

Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase.

Morgan AS, Sanderson PE, Borch RF, Tew KD, Niitsu Y, Takayama T, Von Hoff DD, Izbicka E, Mangold G, Paul C, Broberg U, Mannervik B, Henner WD, Kauvar LM. Morgan AS, et al. Among authors: paul c. Cancer Res. 1998 Jun 15;58(12):2568-75. Cancer Res. 1998. PMID: 9635580

6

Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.

Lehmann S, Paul C, Törmä H. Lehmann S, et al. Among authors: paul c. Clin Cancer Res. 2001 Feb;7(2):367-73. Clin Cancer Res. 2001. PMID: 11234892

7

Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia.

Bogason A, Masquelier M, Lafolie P, Skogastierna C, Paul C, Gruber A, Vitols S. Bogason A, et al. Among authors: paul c. Drug Metab Lett. 2010 Dec;4(4):228-32. doi: 10.2174/187231210792928260. Drug Metab Lett. 2010. PMID: 20670211

8

Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia.

Tidefelt U, Sundman-Engberg B, Paul C. Tidefelt U, et al. Among authors: paul c. Leuk Res. 1994 Apr;18(4):293-7. doi: 10.1016/0145-2126(94)90032-9. Leuk Res. 1994. PMID: 8170171

9

The expression of cellular retinoid binding proteins in non-APL leukemic cells and its association with retinoid sensitivity.

Lehmann S, Paul C, Törmä H. Lehmann S, et al. Among authors: paul c. Leuk Lymphoma. 2002 Apr;43(4):851-8. doi: 10.1080/10428190290016999. Leuk Lymphoma. 2002. PMID: 12153175

10

Myocardial toxicity of high-dose cyclophosphamide in rabbits treated with daunorubicin.

Isberg B, Paul C, Jönsson L, Svahn U. Isberg B, et al. Among authors: paul c. Cancer Chemother Pharmacol. 1991;28(3):171-80. doi: 10.1007/BF00685505. Cancer Chemother Pharmacol. 1991. PMID: 1649704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,195 results

Search Page

Filters